AI-generated summary
This review discusses red light therapy as a possible non-pharmacological influence on thrombosis and hemostasis, noting reported effects on nitric oxide, endothelial function, platelets, and vascular tone. The authors report experimental data suggesting reduced platelet aggregation and improved microvascular perfusion, but state that controversy remains about whether these benefits reflect red or near-infrared light itself. Limitations in tissue penetration, protocol standardization, and clinical trial evidence are acknowledged.
- Limits stated in the abstract
- The abstract notes uncertainty about mechanisms, limited protocol standardization, and a lack of randomized clinical trial evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thieme-connect.de.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Red light therapy, Near-infrared, Photobiomodulation, Far-infrared, Nitric oxide. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.